METHODS A systematic search of studies on the association of SNPs with susceptibility to CAD was conducted in PubMed, Embase, Cochrane Library and CNKI. Odds ratios (ORs) and 95% confidence intervals (95% CIs) were used to pool the effect size. A total of 6 casecontrol studies on rs28362491 in NFKB1-94ATTG were included.
METHODS 583 participants, including 172 cases with aortic valve calcification and 411 controls were selected for the present study. Two SNPs (rs6725189 and rs693) of apoB were genotyped by using the polymerase chain reaction-restriction fragment length (PCR-RFLP) method. Independent-sample t-test, chi-square test and logistic regression were used to analyze.
RESULTS
The rs6725189 was found to be associated with aortic valve calcification in the dominant model, and the difference remained statistically significant following multivariate adjustment (p ¼ 0.036, p ¼ 0.004, respectively). The rs693 was found to be associated with aortic valve calcification in the recessive model, and the difference remained statistically significant following multivariate adjustment (p ¼ 0.004, p ¼ 0.028, respectively).
CONCLUSIONS Both rs6725189 and rs693 of the apoB gene are associated with aortic valve calcification in the Han and Kazak populations of China.
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MtDNA as a biomarkers in acute myocardial infarction and its effects on myocardial cell Jing Liu, Liang Xie, Mingming Xi, Tingsong Liu, Jianbin Gong Jinling Hospital, Nanjing University School of Medicine OBJECTIVES An increasing studies have focused on the phenomenon that mitochondrial DNA (mtDNA) activates innate immunity responses. However, the specific role of mtDNA in acute myocardial infarction remains elusive. This study was designed to examine whether mtDNA can be served as a biomarker of acute myocardial infarction (AMI) patients and try to eliminate the damage effects of mtDNA on cardiomyocyte.
METHODS Plasma nuclear and mtDNA levels were measured by quantitative PCR in 50 AMI patients, 50 non-myocardial infarction (MI) (with MI risk) and 50 healthy control. Purified mtDNA or nuclear DNA was added to H9c2s cells, with or without pretreatment with chloroquine (an inhibitor of endosomal receptors like TLR9). The cell viability and apoptosis were tested by MTT and Flow cytometry, respectively. The levels of TLR9, p-p38 mitogen-activated protein kinase (MAPK) and caspase 3 were detected by western blot.
RESULTS
The concentrations of mtDNA were significantly higher in the AMI group of hospital day 1 than that in the non-MI controls and healthy individuals (3.754AE0.384 ng/mL vs. 1.851AE0.3483 ng/mL, P<0.05; 3.754AE0.384 ng/mL vs. 0.1517AE0.0924 ng/mL, p <0.05) and decreased shortly after PCI. Exogenous mtDNA reduced the viability of H9c2 cells and induced TLR9 and p-p38 MAPK and caspase 3 activation. These effects were inhibited by chloroquine. Nuclear DNA did not induce TLR9, caspase3, p-p38 MAPK activation.
CONCLUSIONS MtDNA level is increased after AMI and can used as a biomarker in AMI patients. MtDNA activates TLR9-P38MAPK and inducing cardiomyocyte cells death.
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Protective effects and its mechanism of Helix B-surface peptide against cardiac microvascular endothelial cell injury induced by ischemia / reperfusion Chen Wang, Rui Si, Mingming Zhang, Rongqing Zhang, Haichang Wang Department of Cardiology, Xijing Hospital, Fourth Military Medical University OBJECTIVES MI/R injury could paradoxically reduce the beneficial effects of myocardial reperfusion and cause contractile dysfunction and cellular damage, lacking of effective strategies of prevention cure. A helix-B surface peptide (HBSP), which is composed of 11 amino acids derived from the aqueous face of helix B of EPO, recently was developed and retained tissue-protective but avoiding erythropoietic property of EPO. Our previous experiment results have demonstrated that HBSP could reduce myocardial ischemia / reperfusion (MI/R) injury of Sprague-Dawley rats and increase the post ischemic myocardial functions via activating the phosphatidylinositol 3-kinase (PI3-K)-Akt cascade. However, it is still unclear whether HBSP can protect the cardiac microvascular endothelial cells (CMECs) when subjected to ischemia / reperfusion injury Therefore, the aims of the present study were to investigate the protective effect of HBSP against cardiac microvascular endothelial cells (CMECs) injury induced by ischemia / reperfusion and further explored the underlying mechanisms involved.
METHODS CMECs isolated from the adult hearts of Sprague-Dawley rats were exposed to hypoxia and ischemia buffer for 2h followed by 4h reoxygenation. Then CMECs were randomized to receive different concentrations of EPO-derived peptides HBSP, EPO, HBSP plus LY294002 (specific inhibitor of PI3K), HBSP plus rapamycin (specific inhibitor of mTOR) at the start of reperfusion. The cell viability of CEMCs was measured by MTT colorimetric assay and the apoptosis of CEMCs was detected by Tunel method. The wound scratch assay and transwell method were performed to detect the migration of CMECs. The expression of p-AKT, p-mTOR and p-p70S6K were analyzed by western blot analysis.
RESULTS Both cell viability and migration ability of CMECs were impaired after SI/R (P <0.01 vs.control), and the apoptotic index increased in comparison with control group (P<0.01). While administration of EPO and HBSP during reperfusion dramatically attenuated the dysfunction of CMECs. Compared with the SI/R group, HBSP treatment in CMECs exerted protective effects as evidenced by the increase of cell viability (P<0.05), inhibited CMECs apoptosis (25.5%AE 0.43% vs. 41.1%AE0.8%, P <0.01) and improved the migration ability of CMECs (P <0.05). Moreover, HBSP caused over Akt phosphorylation in the reperfusion CMECs, which was abrogated by the treatment of LY294002 (P <0.05), but not by rapamycin. Furthermore, mTOR phosphorylation following HBSP treatment was prevented by either LY294002 or rapamycin (P<0.05). Similarly, the phosphorylation of the mTOR downstream molecule p70S6K were up-regulated by HBSP treatment (P <0.05). While treating with LY294002 or rapamycin prevented HBSP-induced phosphorylation of p70S6K (P <0.05). Compared with the HBSP group, the apoptotic index increased while treating with LY294002 or rapamycin (P <0.05).
CONCLUSIONS HBSP might have protective effect of CMECs against ischemia/reperfusion injury, which may be related with activation of PI3K/AKT/mTOR signaling pathway.
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